DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Flupirtine is an investigational drug.
There have been 4 clinical trials for Flupirtine. The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2007.
The most common disease conditions in clinical trials are Sclerosis, Multiple Sclerosis, Relapsing-Remitting, and Multiple Sclerosis. The leading clinical trial sponsors are Ludwig-Maximilians - University of Munich, Charite University, Berlin, Germany, and Bayer.
Recent Clinical Trials for Flupirtine
|Clinical Studies by Using Accelerated PDX Model to Screen Drugs for Advanced Solid Tumor||Haining Health-Coming Biotech Co., Ltd.||Phase 2|
|Effect of the Kv7-channel Opener Flupirtine on the Excitability of Human Peripheral Myelinated Axons in Vivo||Ludwig-Maximilians - University of Munich||Phase 1|
|Pharmacokinetics, Metabolism and Analgesic Effects of Flupirtine||AWD.pharma GmbH & Co. KG||Phase 1|